Sinocelltech Group Limited (SHA:688520)
China · Delayed Price · Currency is CNY 39.89
+2.80 (7.55%)
At close: Mar 6, 2026
Sinocelltech Group Market Cap
Sinocelltech Group has a market cap or net worth of 17.76 billion as of March 6, 2026. Its market cap has increased by 7.06% in one year.
Market Cap
17.76B
Enterprise Value
20.47B
Revenue
1.56B
Ranking
n/a
PE Ratio
n/a
Stock Price
39.89
Market Cap Chart
Since June 22, 2020, Sinocelltech Group's market cap has decreased from 31.81B to 17.76B, a decrease of -44.15%. That is a compound annual growth rate of -9.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 17.76B | -7.90% |
| Dec 31, 2025 | 19.29B | 19.54% |
| Dec 31, 2024 | 16.13B | -32.75% |
| Dec 29, 2023 | 23.99B | -11.11% |
| Dec 30, 2022 | 26.99B | 6.06% |
| Dec 31, 2021 | 25.45B | 28.32% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 22, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| DaShenLin Pharmaceutical Group | 22.11B |
| Suzhou Zelgen Biopharmaceuticals | 20.05B |
| BrightGene Bio-Medical Technology | 17.37B |
| Jinyu Bio-technology | 16.25B |
| Anhui Anke Biotechnology (Group) | 15.70B |
| Inner Mongolia Furui Medical Science | 14.76B |
| Tibet Cheezheng Tibetan Medicine | 14.51B |
| Pacific Shuanglin Bio-pharmacy | 13.16B |